Literature DB >> 31707152

Extended vs. standard-duration thromboprophylaxis in acutely ill medical patients: A systematic review and meta-analysis.

Thita Chiasakul1, Christina R Evans2, Alex C Spyropoulos3, Gary Raskob4, Mark Crowther5, Adam Cuker6.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31707152     DOI: 10.1016/j.thromres.2019.10.027

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  11 in total

1.  Extended thromboprophylaxis for medically ill patients with cancer: a systemic review and meta-analysis.

Authors:  Soravis Osataphan; Rushad Patell; Thita Chiasakul; Alok A Khorana; Jeffrey I Zwicker
Journal:  Blood Adv       Date:  2021-04-27

Review 2.  COVID-19 and coagulopathy.

Authors:  Malay Sarkar; Irappa V Madabhavi; Pham Nguyen Quy; Manjunath B Govindagoudar
Journal:  Clin Respir J       Date:  2021-08-30       Impact factor: 1.761

3.  Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE Trial.

Authors:  Eduardo Ramacciotti; Leandro Barile Agati; Daniela Calderaro; Giuliano Giova Volpiani; Caroline Candida Carvalho de Oliveira; Valéria Cristina Resende Aguiar; Elizabeth Rodrigues; Marcone Lima Sobreira; Edwaldo Edner Joviliano; Cesar Dusilek; Kenji Itinose; Rogério Aparecido Dedivitis; André Sementilli Cortina; Suzanna Maria Viana Sanches; Nara Franzin de Moraes; Paulo Fernando Guimarães Morando Marzocchi Tierno; André Luiz Malavasi Longo de Oliveira; Adriano Tachibana; Rodrigo Caruso Chate; Marcus Vinícius Barbosa Santos; Bruno Bezerra de Menezes Cavalcante; Ricardo Cesar Rocha Moreira; Chang Chiann; Alfonso Tafur; Alex C Spyropoulos; Renato D Lopes
Journal:  Am Heart J       Date:  2021-09-01       Impact factor: 5.099

Review 4.  Post-acute COVID-19 syndrome.

Authors:  Ani Nalbandian; Kartik Sehgal; Aakriti Gupta; Mahesh V Madhavan; Claire McGroder; Jacob S Stevens; Joshua R Cook; Anna S Nordvig; Daniel Shalev; Tejasav S Sehrawat; Neha Ahluwalia; Behnood Bikdeli; Donald Dietz; Caroline Der-Nigoghossian; Nadia Liyanage-Don; Gregg F Rosner; Elana J Bernstein; Sumit Mohan; Akinpelumi A Beckley; David S Seres; Toni K Choueiri; Nir Uriel; John C Ausiello; Domenico Accili; Daniel E Freedberg; Matthew Baldwin; Allan Schwartz; Daniel Brodie; Christine Kim Garcia; Mitchell S V Elkind; Jean M Connors; John P Bilezikian; Donald W Landry; Elaine Y Wan
Journal:  Nat Med       Date:  2021-03-22       Impact factor: 53.440

5.  Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum.

Authors:  Geoffrey D Barnes; Allison Burnett; Arthur Allen; Marilyn Blumenstein; Nathan P Clark; Adam Cuker; William E Dager; Steven B Deitelzweig; Stacy Ellsworth; David Garcia; Scott Kaatz; Tracy Minichiello
Journal:  J Thromb Thrombolysis       Date:  2020-07       Impact factor: 2.300

6.  Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study.

Authors:  Jason B Hill; David Garcia; Mark Crowther; Bryan Savage; Shira Peress; Kevin Chang; Steven Deitelzweig
Journal:  Blood Adv       Date:  2020-11-10

7.  Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units.

Authors:  Andrew J Doyle; Will Thomas; Andrew Retter; Martin Besser; Stephen MacDonald; Karen A Breen; Michael J R Desborough; Beverley J Hunt
Journal:  Thromb Res       Date:  2020-10-08       Impact factor: 3.944

8.  Thrombotic and Hemorrhagic Incidences in Patients After Discharge from COVID-19 Infection: A Systematic Review and Meta-Analysis.

Authors:  Tarinee Rungjirajittranon; Weerapat Owattanapanich; Nattawut Leelakanok; Natthaporn Sasijareonrat; Bundarika Suwanawiboon; Yingyong Chinthammitr; Theera Ruchutrakool
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

9.  Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older.

Authors:  Walter Ageno; Renato D Lopes; Mark Goldin; Roger D Yusen; Gregory W Albers; Gregory C Elliott; Jonathan L Halperin; William R Hiatt; Gregory Maynard; Philippe Gabriel Steg; Jeffrey I Weitz; Eunyoung Suh; Wentao Lu; Elliot S Barnathan; Gary E Raskob; Alex C Spyropoulos
Journal:  J Thromb Haemost       Date:  2021-08-17       Impact factor: 16.036

10.  Post-discharge thrombosis and bleeding in medical patients: A novel risk score derived from ubiquitous biomarkers.

Authors:  Scott C Woller; Scott M Stevens; Masarret Fazili; James F Lloyd; Emily L Wilson; Gregory L Snow; Joseph R Bledsoe; Benjamin D Horne
Journal:  Res Pract Thromb Haemost       Date:  2021-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.